GCC Biopsy Devices Market to Reach US$ 72.4 Million by 2032, Accelerated by Rising Incidence of Chronic Diseases

June 29, 2023 | Healthcare

As per the latest report by IMARC Group, titled "GCC Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Country 2024-2032," the GCC biopsy devices market size reached US$ 46.2 Million in 2023. Biopsy devices are medical equipment used to extract sample cells and tissues from an organ. Needles, localization wires, biopsy guns, and forceps are some of the commonly used biopsy devices. They are manufactured using high-quality materials such as stainless steel, titanium, or disposable plastic components. These devices undergo strict quality control measures to ensure their safety and reliability. They are used in minimally invasive (MI) procedures to reduce patient discomfort and recovery time. Biopsy devices are also used imaging technologies such as ultrasound, magnetic resonance imaging (MRI), or computerized tomography (CT) scan guidance to assist in accurate targeting of the biopsy site. Currently, there are several types of biopsy devices available in the GCC market, each catering to specific medical requirements, including fine-needle aspiration (FNA) biopsy devices, core needle biopsy, and vacuum-assisted biopsy devices.

GCC Biopsy Devices Market Trends:

The GCC biopsy devices market is being accelerated by various factors, including the rising incidence of chronic diseases, such as cancer. Moreover, the expanding healthcare infrastructure, including hospitals, diagnostic centers, and research institutions, and the growing awareness among patients and healthcare providers about the benefits of early detection and personalized treatment are propelling the market growth. Furthermore, rapid advancements in imaging technologies and their integration with biopsy devices have significantly improved the accuracy and success rates of biopsies, which is creating a positive outlook for the market. Moreover, the availability of real-time imaging guidance, such as ultrasound or MRI, and the continuous development of novel biopsy techniques, such as liquid biopsies, which analyze circulating tumor cells or genetic material, are driving the market growth. Besides this, the increasing geriatric population, which is more susceptible to various diseases, and the growing preference for minimally invasive (MI) procedures are providing an impetus to the market growth. Additionally, governments of various nations are undertaking initiatives and offering favorable reimbursement policies, which is boosting the market growth. In line with this, key players are introducing new product variants with better visualization and guidance due to the escalating demand for precision medicine and personalized treatment approaches, which is supporting the market growth. Other factors, such as the integration of artificial intelligence (AI) and machine learning (ML) algorithms in biopsy devices, the burgeoning healthcare expenditure, the rapid expansion of the private healthcare sector and medical tourism, and increasing research and development (R&D) activities to enhance the efficacy of biopsy devices, are influencing the market growth. Looking forward, the market value is projected to reach US$ 72.4 Million by 2032, expanding at a CAGR of 4.98% during 2024-2032.

Market Summary: 

  • By the procedure type, the market is bifurcated into surgical biopsy and needle biopsy.
  • Based on the product, the market is divided into biopsy guidance systems, needle-based biopsy guns, biopsy needles, biopsy forceps, and others.
  • On the basis of the application, the market is segregated into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others.
  • By the guidance technique, the market is categorized into ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and others.
  • Based on the end user, the market is segmented into hospitals and clinics, academic and research institutes, and others.
  • On the basis of the country, the market has been categorized into Saudi Arabia, UAE, Qatar, Oman, Kuwait, and Bahrain.
  • The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Procedure Type, Product, Application, Guidance Technique, End User, Country
Countries Covered Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
GCC Biopsy Devices Market to Reach US$ 72.4 Million by 2032, Accelerated by Rising Incidence of Chronic Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More